anti-CD3/anti-CD79b bispecific T-cell engager TDB (Genentech)

N/A

Report date: 2026/03/19 16:58:29

Base Information

Drug Nameanti-CD3/anti-CD79b bispecific T-cell engager TDB (Genentech)
Drug Alias Nameanti-CD79b/CD3 T-cell-dependent bispecific antibodies (Genentech)anti-CD79b/CD3 TDB (Genentech)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsB-cell antigen receptor complex-associated protein beta chain modulators
TargetsT cell surface glycoprotein CD3B-cell antigen receptor complex-associated protein beta chain
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesGenentech Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A